NEU neuren pharmaceuticals limited

My interpretation of Sillazze’s post was that with the recent...

  1. 6 Posts.
    My interpretation of Sillazze’s post was that with the recent patent granting for 2591 in PH, we could then start the application for patent approval in Europe, thereby securing the intellectual property for a second indication (with Acadia going through the process for Daybue), possibly making more it more attractive to a potential suitor. This could mean that qualifying criteria for some of the long term incentives options recently announced would be met. Either that or I have no clue what so ever!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.